Evoke Pharma Inc
NASDAQ:EVOK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evoke Pharma Inc
NASDAQ:EVOK
|
US |
|
S
|
SEI Medical PCL
SET:SEI
|
TH |
|
Tasty PLC
LSE:TAST
|
UK |
|
KTMG Ltd
SGX:XCF
|
SG |
|
N
|
NetApp Inc
XBER:NTA
|
US |
|
P
|
PPB Group Bhd
KLSE:PPB
|
MY |
|
L
|
Letus Capital SA
WSE:LET
|
PL |
|
B
|
Bioventus Inc
NASDAQ:BVS
|
US |
|
JW Pharmaceutical Corp
KRX:001060
|
KR |
|
C
|
Carrefour SA
F:CAR
|
FR |
|
S
|
Selena FM SA
WSE:SEL
|
PL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVOK's stock price target?
Not Available
EVOK does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Evoke Pharma Inc?
Projected CAGR
52%
The compound annual growth rate for Revenue over the next 3 years is 52%.